FinancialContent is the trusted provider of stock market information to the media industry.
June 20, 2012 at 15:15 PM EDT
Keraplast extends wound care distribution network to Turkey

San Antonio, June 20, 2012 (GLOBE NEWSWIRE) -- Keraplast Technologies, LLC the developer of ReplicineTM Functional Keratin®Advanced Wound care products announced today having entered an agreement with Gramatek Ltd, for distribution of their advanced wound care products to Hospitals and wound care centers throughout Turkey.  Partnering with Gramatek provides Keraplast access to Hospitals, Clinics and strategic Points of service centers throughout key regional areas of Turkey, said Michael Espensen, CEO of Keraplast Technologies, LLC.  "We are extremely pleased to enter into this agreement with such an esteemed organization and to provide members served by Gramatek with our paradigm changing line of Replicine™ Functional Keratin® products. Clinicians in many regions of the world, including the USA, Europe, Australia, New Zealand, South Africa, and now Turkey can utilize the latest clinical advancement in wound healing. The global interest in kerasorb®, keramatrix®, keragel™ and keragelT™ is expanding quickly and were putting in a strong network to provide good support wherever the products are in demand".

 
About Gramatek, a biomedical distributor of innovative wound care products based in Ankara, Turkey uses its extensive experience and network to bring the latest wound treatment solutions to the Turkish health sector. "With Keraplast not only did we find a very strong scientific team and organization, but also a company that carries in its portfolio unique and advanced wound treatment products which will prove to be very beneficial for the Turkish public. We are excited at the prospect of fruitful cooperation." said Ayten Boz, GM of Gramatek, Ltd.

About Keraplast, a privately held company founded in 1996, is the first and only commercial manufacturer of proprietary Bioactive Keratin products. Headquartered in San Antonio, Texas. Keraplast manufactures ReplicineTM Functional Keratin® wound care products with FDA and CE mark clearance for sale around the world, as well as a wide range of skin care, hair care and nutritional solutions using proprietary keratin technology.

 http://www.globenewswire.com/newsroom/prs/?pkgid=13375

CONTACT: Dr. Rob Kelly; Rob.Kelly@keraplast.com;  210-591-8573
         William Moore; bill@keraplast.com;  210-494-5596
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More